Healthy Skepticism Library

Items published during the years 2000 to 2009

There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.

Page 95 of 144 pages ‹ First  < 93 94 95 96 97 >  Last ›

HSL5578
Chalmers I, Matthews R.
What are the implications of optimism bias in clinical research?
Lancet 2006 Feb 11; 367:(9509):449-50
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(06)68153-1

HSL20034
Limprecht E
Consumer call for end to drug reps
Australian Doctor 2006 Feb 105
http://www.australiandoctor.com.au/news/latest-news/consumer-call-for-end-to-drug-reps

HSL4792
Flaten O.
[Are children getting the right drugs?]
Tidsskr Nor Laegeforen 2006 Feb 9;126(4):481 2006 Feb 9; 126:(4):481
http://www.tidsskriftet.no/pls/lts/pa_lt.visSeksjon?vp_SEKS_ID=1341354

HSL3816
Kaufman M.
Former FDA Chief Joins Lobby Shop
Washington Post 2006 Feb 8
http://www.washingtonpost.com/wp-dyn/content/article/2006/02/07/AR2006020701693.html

HSL3815
Ready T.
Divided Loyalties?
Washington Post 2006 Feb 7
http://www.washingtonpost.com/wp-dyn/content/article/2006/02/06/AR2006020601180.html

HSL4825
McKillop T.
Does the European pharmaceutical industry have a future?
Circulation 2006 Feb 7; 113:(5):f19-20
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3051&uid=16468149&db=PubMed&url=http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=16468149

HSL3818
Abbott T.
Tony Abbott: Best forum for RU486 decision
The Australian Newspaper 2006 Feb 6
http://www.theaustralian.news.com.au/common/story_page/0,5744,18048967%255E7583,00.html

HSL3832
Welch A.
Yamada to Lead Gates Foundation’s Global Health Program
Global Health 2006 Feb 6
http://www.globalhealth.org/news/article/7114

HSL4762
Tanne JH.
NEJM editor gives pretrial evidence in Vioxx case.
BMJ 2006 Feb 4; 332:(7536):255
http://bmj.bmjjournals.com/cgi/content/full/332/7536/255-a

HSL4735
Kumar PD.
Thiamine shortage--plight of low-cost, lifesaving orphan drugs.
N Engl J Med 2006 Feb 2; 354:(5):532-3

HSL4736
Haffner ME.
Adopting orphan drugs--two dozen years of treating rare diseases.
N Engl J Med 2006 Feb 2; 354:(5):445-7
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3051&uid=16452556&db=PubMed&url=http://content.nejm.org/cgi/pmidlookup?view=short&pmid=16452556

HSL4533
Wasowicz L.
Is childhood a mental problem?
United Press International 2006 Feb 1
http://news.monstersandcritics.com/lifestyle/consumerhealth/printer_1094005.php

HSL4777
Andre T, De Gramont A.
[A good cooperation between industry and French medical oncologists]
Bull Cancer. 2006 Feb 01; 93:(Supp 1):S3-4
http://www.john-libbey-eurotext.fr/fr/revues/medecine/bdc/e-docs/00/04/16/5D/resume.md

HSL4808
Nystrand A.
[The examples Cancer Foundation, Heart-Lung foundation and Child Cancer Foundation: aggressive marketing undermines confidence].
Lakartidningen 2006 Feb 1-7; 103:(5):306-7

HSL4883
Nau JY.
[The OMS demands an immediate end to the commercialization of antimalarials only consisting of artemisinine].
Rev Med Suisse 2006 Feb 1; 2:(51):359

HSL4931
Coleman DL, Kazdin AE, Miller LA, Morrow JS, Udelsman R.
Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach.
Acad Med 2006 Feb 01; 81:(2):154-60
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3159&uid=16436576&db=PubMed&url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=1040-2446&volume=81&issue=2&spage=154

HSL4936
Gori GB.
Daubert's menace.
Am J Public Health 2006 Feb 01; 96:(2):206
http://www.ajph.org/cgi/content/full/96/2/206

HSL5162
Lexchin J .
Withdrawals of drugs for safety reasons: How do regulators decide if they are too unsafe?
Reaction Bulletin 2006 Feb 1; 236:

HSL5208
Hammond I.
Selling sickness.
Can Assoc Radiol J 2006 Feb 01; 57:(1):11-2

HSL5221
Sarek M.
Evident exception in clinical practice not sufficient to break traditional hypothesis.
PLoS Med 2006 Feb 01; 3:(2):e120
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030120

HSL5222
Rickels K.
Consumer advertising can be misleading.
PLoS Med 2006 Feb 01; 3:(2):e119
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030119

HSL5223
McCarter G.
Should industry speak the loudest in informing the public on medical matters?
PLoS Med 2006 Feb 01; 3:(2):e118
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030118

HSL5224
Oaks D.
Why did the FDA approve these advertisements?
PLoS Med 2006 Feb 01; 3:(2):e117
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030117

HSL5225
Goldstein S.
Is ADHD a growth industry?
J Atten Disord 2006 Feb 01; 9:(3):461-4
http://jad.sagepub.com/cgi/reprint/9/3/461

HSL5442
Williams R.
A better code for a better relationship. Interview by Paul C Adams.
Can J Gastroenterol 2006 Feb 01; 20:(2):73-4

HSL5444
Tanner JA.
WTO TRIPS and its effect on the supply and development of medicines in China.
Hong Kong Med J 2006 Feb 01; 12:(1):84-6
http://www.hkmj.org.hk/hkmj/abstracts/v12n1/84.htm

HSL5446
Wilson N, Signal L, Nicholls S, Thomson G.
Marketing fat and sugar to children on New Zealand television.
Prev Med 2006 Feb 01; 42:(2):96-101
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WPG-4HR728W-3&_coverDate=02%2F28%2F2006&_alid=421626197&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6990&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=714528a780249b523be8cf34df8dcd63

HSL5674
Mansoor LE, Dowse R.
Medicines information and adherence in HIV/AIDS patients.
J Clin Pharm Ther 2006 Feb 01; 31:(1):7-15
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2710.2006.00696.x

HSL5779
Lazarus A.
Pharmaceutical policy issues for medical schools.
Psychiatr Serv 2006 Feb 01; 57:(2):167
http://ps.psychiatryonline.org/cgi/content/full/57/2/167

HSL5929
Flint DH, Hernandez-Marrero P, Wielemaker M.
Polarization of perceived Procedural Justice.
Percept Mot Skills 2006 Feb 01; 102:(1):35-50

HSL6085
Neuman Y, Weinstock MP, Glasner A.
The effect of contextual factors on the judgement of informal reasoning fallacies.
Q J Exp Psychol (Colchester) 2006 Feb 01; 59:(2):411-25
http://taylorandfrancis.metapress.com/(plhysy552ldahz45qjfxxl55)/app/home/contribution.asp?referrer=parent&backto=issue,13,14;journal,11,12;linkingpublicationresults,1:113514,1

HSL6274
Keng CJ, Lin HY.
Impact of telepresence levels on internet advertising effects.
Cyberpsychol Behav 2006 Feb 01; 9:(1):82-94
http://www.liebertonline.com/doi/abs/10.1089/cpb.2006.9.82

HSL6399
Dainesi SM.
Seeking harmonization and quality in clinical trials.
Clinics 2006 Feb 01; 61:(1):3-8
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322006000100002&tlng=en&lng=en&nrm=iso

HSL19877
Gressor M
Game of the name
The Sydney Morning Herald - Health and Science Supplement 2006 Feb 1
http://www.smh.com.au/news/health-and-fitness/game-of-the-name/2006/02/01/1138590559467.html

HSL4606
Heres S, Davis J, Maino K, Jetzinger E, Kissling W, Leucht S.
Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.
Am J Psychiatry 2006 Feb; 163:(2):185-94
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3051&uid=16449469&db=PubMed&url=http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=16449469

HSL4842
Autret-Leca E, Bensouda-Grimaldi L, Le Guellec C, Jonville-Bera AP.
[Prescriptions and children].
Arch Pediatr 2006 Feb; 13:(2):181-5
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3048&uid=16343869&db=pubmed&url=http://linkinghub.elsevier.com/retrieve/pii/S0929-693X(05)00602-0

HSL4851
Panday S, Richter L, Bhana A.
Young adults, the target of below-the-line advertising.
S Afr Med J 2006 Feb; 96:(2):104-5

HSL4864
Marris E.
New law offers drug makers sweeping protection against lawsuits.
Nat Med 2006 Feb; 12:(2):154
http://www.nature.com/doifinder/10.1038/nm0206-154a

HSL4865
Wadman M.
Earlier drug tests on people could be unsafe, critics warn.
Nat Med 2006 Feb; 12:(2):153
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3094&uid=16462779&db=PubMed&url=http://dx.doi.org/10.1038/nm0206-153

HSL4878
Murphy MT.
Is continuing education morphing into dental infomercials?
Dent Today 2006 Feb; 25:(2):12

HSL4879
Counterfeit medicines: the silent epidemic.
Indian J Med Sci 2006 Feb; 60:(2):82-3

HSL4884
McEleney P.
A case of mislabelling.
J Perioper Pract 2006 Feb; 16:(2):63

HSL4924
Faustino P, Chan CC, Carrano J, Gosnell M, Gu ZQ, Maule A, Sigvardson K, Zhang YF.
Report on the PQRI impurity characterization and quantification best practices survey.
Pharm Res 2006 Feb; 23:(2):440-6
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3055&uid=16477396&db=PubMed&url=http://dx.doi.org/10.1007/s11095-005-9646-x

HSL4932
Gardner MN, Brandt AM.
'The doctors' choice is America's choice': the physician in US cigarette advertisements, 1930-1953.
Am J Public Health 2006 Feb; 96:(2):222-32
http://www.ajph.org/cgi/content/full/96/2/222

HSL4933
MacLennan AH, Sturdee DW.
The 'bioidentical/bioequivalent' hormone scam.
Climacteric 2006 Feb; 9:(1):1-3

HSL4977
Espino DV, Bazaldua OV, Palmer RF, Mouton CP, Parchman ML, Miles TP, Markides K.
Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE Study.
J Gerontol A Biol Sci Med Sci 2006 Feb; 61:(2):170-5
http://biomed.gerontologyjournals.org/cgi/content/full/61/2/170

HSL5041
Roggla G, Moser B.
Re: Bioethics, the Surviving Sepsis Campaign, and the industry.
Wien Klin Wochenschr 2006 Feb; 118:(1-2):65

HSL5042
Ricevuti G, Gasparetto C.
Re: Bioethics, the Surviving Sepsis Campaign, and the industry.
Wien Klin Wochenschr 2006 Feb; 118:(1-2):64-5

HSL5043
Mackenzie AF.
Re: Bioethics, the Surviving Sepsis Campaign, and the industry.
Wien Klin Wochenschr 2006 Feb; 118:(1-2):64

HSL5044
Malliani A.
Re: Bioethics, the Surviving Sepsis Campaign, and the industry.
Wien Klin Wochenschr 2006 Feb; 118:(1-2):63-4

HSL5046
Bion J, Vincent JL, Angood P.
Bioethics, the Surviving Sepsis Campaign and the industry.
Wien Klin Wochenschr 2006 Feb; 118:(1-2):63

HSL5047
Genuis SK, Genuis SJ.
Exploring the continuum: medical information to effective clinical practice. Paper I: the translation of knowledge into clinical practice.
J Eval Clin Pract 2006 Feb; 12:(1):49-62
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2753.2005.00609.x

HSL5075
Sfikas PM.
Federal appeals court says no to first amendment claim in telemarketing case.
J Am Dent Assoc 2006 Feb; 137:(2):241-2

HSL5096
Ridgway WE.
Realizing two-tiered innovation policy through drug regulation.
Stanford Law Rev 2006 Feb; 58:(4):1221-50

HSL5541
Shah MB, Bentley JP, McCaffrey DJ 3rd.
Evaluations of care by adults following a denial of an advertisement-related prescription drug request: The role of expectations, symptom severity, and physician communication style.
Soc Sci Med 2006 Feb; 62:(4):888-899
http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description

HSL8799
Mykytyn CE.
Anti-aging medicine: a patient/practitioner movement to redefine aging.
Soc Sci Med 2006 Feb; 62:(3):643-53
http://linkinghub.elsevier.com/retrieve/pii/S0277-9536(05)00305-9

HSL8800
Hollander I.
Viagra's rise above women's health issues: an analysis of the social and political influences on drug approvals in the United States and Japan.
Soc Sci Med 2006 Feb; 62:(3):683-93
http://linkinghub.elsevier.com/retrieve/pii/S0277-9536(05)00317-5

HSL9261
Engelhardt N, Feiger AD, Cogger KO, Sikich D, DeBrota DJ, Lipsitz JD, Kobak KA, Evans KR, Potter WZ.
Rating the raters: assessing the quality of Hamilton rating scale for depression clinical interviews in two industry-sponsored clinical drug trials.
J Clin Psychopharmacol 2006 Feb; 26:(1):71-4
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00004714-200602000-00015

HSL11677
Wehling M.
Translational medicine: can it really facilitate the transition of research "from bench to bedside"?
Eur J Clin Pharmacol 2006 Feb; 62:(2):91-5
http://www.springerlink.com/content/7782201555m7310x/

HSL12502
Groves T.
How honest can a medical journal be?
Aust N Z J Obstet Gynaecol 2006 Feb; 46:(1):2-3
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1479-828X.2006.00505.x

HSL12595
Piette JD, Heisler M, Horne R, Caleb Alexander G.
A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures.
Soc Sci Med 2006 Feb; 62:(4):846-57
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-4GV983T-4&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=3aa5f1b29cf6371fe25722c02e9b48e2

HSL13285
Kapmeyer A, Meyer C, Kochen MM, Himmel W.
Doctors' strategies in prescribing drugs: the case of mood-modifying medicines.
Fam Pract 2006 Feb; 23:(1):73-9
http://fampra.oxfordjournals.org/cgi/content/full/23/1/73

HSL4764
Laupacis A.
On bias and transparency in the development of influential recommendations.
CMAJ 2006 Jan 31; 174:(3):335-6
http://www.cmaj.ca/cgi/pmidlookup?view=long&pmid=16446476

HSL4778
Romano M.
Fighting graft--it's academic. Medical centers must embrace conflict rules: critics.
Mod Healthc 2006 Jan 30; 36:(5):8-10

HSL4824
Prescription drug package inserts get a user-friendly makeover.
Med Health 2006 Jan 30; 60:(6):2-3,

HSL4737
Lenzer J.
US agency wants to limit lawsuits against drug manufacturers.
BMJ 2006 Jan 28; 332:(7535):196
http://bmj.bmjjournals.com/cgi/content/full/332/7535/196-d

HSL4996
Global Framework for Essential Health R&D
CONSUMERS INTERNATIONAL 2006 Jan 26

HSL19952
Ed.
Pressure test your brand strategy
eyeforpharma.com 2006 Jan 26
http://social.eyeforpharma.com/marketing/pressure-test-your-brand-strategy

HSL3828
Connolly C.
Distance Sought Between Doctors and Drug Industry
Distance Sought Between Doctors and Drug Industry 2006 Jan 25
http://www.washingtonpost.com/wp-dyn/content/article/2006/01/24/AR2006012401483.html

HSL4776
Jarhult B.
[Let the profit from drug advertisement in Lakartidningen go to a research foundation!].
Lakartidningen 2006 Jan 25-31; 103:(4):226

HSL4841
Harris G.
In article, doctors back ban on drug companies' gifts; concerns cited on quality of patient care.
NY Times (Print) 2006 Jan 25; A14:

HSL7447
Brennan TA, Rothman DJ, Blank L, Blumenthal D, Chimonas SC, Cohen JJ, Goldman J, Kassirer JP, Kimball H, Naughton J, Smelser N.
Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.
JAMA 2006 Jan 25; 295:(4):429-33
http://jama.ama-assn.org/cgi/content/full/295/4/429

HSL4779
Food and Drug Administration, HHS.
Requirements on content and format of labeling for human prescription drug and biological products. Final rule.
Fed Regist 2006 Jan 24; 71:(15):3921-97
http://a257.g.akamaitech.net/7/257/2422/01jan20061800/edocket.access.gpo.gov/2006/pdf/06-545.pdf

HSL4739
Fontanarosa PB, DeAngelis CD.
JAMA's policy on industry sponsored studies.
BMJ 2006 Jan 21; 332:(7534):177
http://bmj.bmjjournals.com/cgi/content/full/332/7534/177

HSL4765
Herrling P.
Experiments in social responsibility.
Nature 2006 Jan 19; 439:(7074):267-8
http://www.nature.com/doifinder/10.1038/439267a

HSL4740
Clarke JT.
Is the current approach to reviewing new drugs condemning the victims of rare diseases to death? A call for a national orphan drug review policy.
CMAJ 2006 Jan 17; 174:(2):189-90
http://www.cmaj.ca/cgi/content/full/174/2/189

HSL8519
Lexchin J.
Is there still a role for spontaneous reporting of adverse drug reactions?
CMAJ 2006 Jan 17; 174:(2):191-2
http://www.cmaj.ca/cgi/content/full/174/2/191

HSL4889
Cina J, Fanikos J, Mitton P, McCrea M, Churchill W.
Medication errors in a pharmacy-based bar-code-repackaging center.
Am J Health Syst Pharm 2006 Jan 15; 63:(2):165-8
http://www.ajhp.org/cgi/content/full/63/2/165

HSL4709
Day M.
UK drug companies must disclose funding of patients' groups.
BMJ 2006 Jan 14; 332:(7533):69
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3051&uid=16410564&db=PubMed&url=http://bmj.com/cgi/pmidlookup?view=long&pmid=16410564

HSL3672
Henderson D.
Glaxo plans sales curbs for diet pill
The Boston Globe 2006 Jan 13
http://www.boston.com/business/healthcare/articles/2006/01/13/glaxo_plans_sales_curbs_for_diet_pill/

HSL4710
Fisher CB.
Public health. Clinical trials results databases: unanswered questions.
Science 2006 Jan 13; 311:(5758):180-1
http://www.sciencemag.org/cgi/content/full/311/5758/180

HSL3673
Genentech/Biogen Idec: wearing the drug marketing suit well?
Pharmaceutical Business Review 2006 Jan 12
http://www.pharmaceutical-business-review.com/article_feature.asp?guid=5C379035-9AD6-4724-AB96-3ABBD2D9B871

HSL3674
Kang P.
Forest Labs' Mylan Deal Alleviates Pipeline Concerns
Forbes.com 2006 Jan 12
http://www.forbes.com/technology/sciences/2006/01/12/forest-labs-mylan-nebivolol-0112markets03.html

HSL3675
Watts W.
Senators question research grants: Grassley: 'Educational' grants used for drug marketing
MarketWatch 2006 Jan 11
http://www.marketwatch.com/news/yhoo/story.asp?source=blq/yhoo&siteid=yhoo&dist=yhoo&guid=%7BC11F8C93%2D3FD4%2D4119%2DBBC5%2D71B607F8DD5D%7D

HSL3586
Ayers C.
The rise of the rah-rah reps
Times Online 2006 Jan 9
http://www.timesonline.co.uk/article/0,,8123-1973793,00.html

HSL3498
Abramson J.
Drug profits infect medical studies
Los Angeles Times 2006 Jan 7
http://www.latimes.com/news/printedition/opinion/la-oe-abramson7jan07,1,4571818.story

HSL1805
Society of General Internal Medicine
Policy on acceptance and disclosure of external funds
Society of General Internal Medicine 2006 Jan 6
http://www.sgim.org/PDF/SocietyInfo/ExternalFundsPolicyJan2006.pdf

HSL3494
Hensley S.
Pfizer Struggles As Generics Pummel Its Drugs
Hartford Courant ( courant.com) 2006 Jan 6
http://www.courant.com/business/hc-pfizer.artjan06,0,2429494.story?coll=hc-headlines-business

HSL3493
Glaxo says two of its drugs cause eye swelling
bizjournals.com 2006 Jan 5
http://biz.yahoo.com/bizj/060105/1211873.html?.v=1

HSL3496
Roche Holding Defends Drug Advertisement
Associated Press 2006 Jan 5
http://biz.yahoo.com/ap/060105/switzerland_roche_ad_dispute.html?.v=1

HSL3497
FDA Asks Advisory Committee To Examine Cardiovascular Risks Of ADHD Medications
kaisernetwork.org ( The Henry J. Kaiser Family Foundation) 2006 Jan 5
http://www.medicalnewstoday.com/medicalnews.php?newsid=35781

HSL3499
Use Of Nicotine Patches, Gum In First 12 Weeks Of Pregnancy Can Increase Risk Of Birth Defects, Study Says
kaisernetwork.org ( The Henry J. Kaiser Family Foundation) 2006 Jan 5
http://www.medicalnewstoday.com/medicalnews.php?category=41

HSL3495
Smith A.
The antidepressants to watch in '06
CNN/Money 2006 Jan 4
http://money.cnn.com/2006/01/04/news/companies/antidepressants/?cnn=yes

HSL3501
Rosen M.
Biotech flourishes in 2005 while Big Pharma is on the decline
Wisconsin Technology Network 2006 Jan 4
http://wistechnology.com/article.php?id=2582

HSL3580
Roner L.
Can pharma find new solutions to some old problems in 2006?
Eye For Pharma 2006 Jan 4
http://www.eyeforpharma.com/index.asp?nli=o&g-p&nld=1/4/2006&news=49251

HSL3581
Armstrong J.
A new approach to pharmaceutical sales and marketing: Sustainable competitive advantage through psychographic segmentation
Eye For Pharma 2006 Jan 4
http://www.eyeforpharma.com/index.asp?nli=o&g-p&nld=1/4/2006&news=49249

HSL4796
Junod AF.
[A misleading panacea?]
Rev Med Suisse 2006 Jan 4; 2:(47):74

HSL3582
J&J Says It Missed 2 Deaths in Drug Study
Associated Press 2006 Jan 3
http://biz.yahoo.com/ap/060103/j_j_heart_drug.html?.v=2

HSL3583
Chu W.
Penicillin and Amoxicillin's days are numbered
in-Pharma Technologist.com 2006 Jan 3
http://www.in-pharmatechnologist.com/news/ng.asp?n=64680-antibiotic-resistance-penicillin-amoxicillin

HSL3584
New Year's Eve Viagra ad labelled 'reckless'
PM live .com 2006 Jan 3
http://www.pmlive.com/doaa/news.cfm?showArticle=1&ArticleID=4293

Page 95 of 144 pages ‹ First  < 93 94 95 96 97 >  Last ›